You are invited to a seminar by Dr Stephanie Tan who will be visiting Canberra this month. Dr Tan is visiting ANU, from Singapore, to interact with those involved with clinical trials in the ACT, and share learnings and opportunities. As part of her visit, Dr Tan will be presenting a seminar on clinical trials and sharing her experiences from Australia and Singapore in relation to clinical trials.
Clinical trials are important for the development of new treatments as well as discovering new ways to detect, diagnose and reduce the risk of diseases. Investment in clinical trials saves lives and improve health, not to mention the multiple economic flow-on benefits it brings too. This presentation will compare the clinical trials of two countries, Australia and Singapore with an extended discussion on the impact of government prioritisation in Singapore and the challenges associated with operating clinical trial units in Asia.
About Dr Stephanie Tan
Dr Stephanie Tan is currently the Deputy Director of Investigational Medicine Unit (IMU) at National University Health System (NUHS). She oversees the service delivery of IMU, an early phase clinical trials unit and leads new initiatives in clinical trials education and training with an aim to improve the current clinical trial ecosystem in Singapore. She obtained her medical degree from The University of Melbourne and practiced full time for 11 years across a variety of disciplines before venturing into a clinical trials administrator/ managerial role. Her journey in clinical trials started as a co-investigator at the Skin and Cancer Foundation Victoria where she assisted her professor in scaling up the clinical trials activities at the Skin and Cancer Foundation Victoria. She left Melbourne in pursuit of a regional leadership role at a multinational contract research organisation (IQVIA). She was recruited by National University Health System Singapore in 2017 to turn around an underperforming clinical trials unit at the National University Hospital while managing three other portfolios in the clinical trials space.
Stephanie is passionate about clinical trials because it provides hope to patients with limited or no treatment options. Improving patient care is at the center of every initiative she has led or developed. She is constantly creating or building user centric processes to improve or optimise existing clinical trials processes.